We recently established organoid models from normal and neoplastic murine and human pancreas tissues. These organoids exhibit ductal- and disease stage-specific characteristics and, after orthotopic transplantation, recapitulate the full spectrum of tumor progression. Pancreatic organoid technology provides a novel platform for the study of tumor biology and the discovery of potential biomarkers, therapeutics, and personalized medicine strategies.
No takes yet. Share an insight, caveat, or question.
Boj et al. (2015) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: